Hepatology
News
Strong support to provide DAA therapy to all patients with HCV
The findings highlight a “substantial need to provide DAA therapy to all patients with HCV, regardless of disease stage or financial status.”
News
Nonheavy alcohol use associated with liver fibrosis, NASH
“Our results call this strict categorization into question, suggesting that even nonheavy alcohol use should be considered as a factor...
Commentary
How a cheap liver drug may be the key to preventing COVID
The authors of a paper appearing in Nature give us multiple, complementary lines of evidence.
Conference Coverage
Bepirovirsen: Is a ‘functional cure’ for HBV on the horizon?
“Bepirovirsen is just one RNA-based HBV therapy now being pursued. Several other antisense RNAs as well as the more malleable small interfering...
Conference Coverage
Liver disease-related deaths rise during pandemic
“The increasing trend in mortality rates for ALD and NAFLD has been quite alarming, with disparities in age, race, and ethnicity.”
Conference Coverage
World falls short on HBV, HCV elimination targets
“As countries progress toward eliminating hepatitis B and C, we really need to do more to expand political will and financing of national...
News
COVID tied to spike in deaths in chronic liver disease with diabetes
“Our observations confirm that COVID-19 had a higher likelihood of impacting vulnerable populations with pre-existing chronic liver diseases and...
News
FDA okays terlipressin (Terlivaz) injection for hepatorenal syndrome
The synthetic vasopressin analog is an injectable medication indicated for patients with hepatorenal syndrome experiencing rapid deterioration of...
News
Pervasive ‘forever chemical’ linked to liver cancer
People can limit exposure by avoiding water contaminated with ‘forever chemicals’ or filtering it.
News
Neighborhood factors contribute to liver cancer disparities in Texas
HCC is the most common type of liver cancer in the United States, and Texas has the highest rate.